Becker's Healthcare August 27, 2019
By Joel Diamond MD, FAAP, Chief Medical Officer of 2bPrecise, an Allscripts company

With the age of precision medicine upon us, many healthcare leaders seek clarity about return on investment. To fully leverage precision medicine, they realized their organizations will need to implement new software, reconfigure workflows, and educate both providers and patients.

Not a small, or inexpensive, undertaking. They want to be sure they will realize benefit, both when treating individuals and populations of patients.

Here are five examples of where significant value can be realized by precision medicine leaders and innovators using genomics at the point of care as a key component of clinical decision support.

Clinical value

1. The CDC reports that 102 million Americans have cholesterol levels above 200 mg/dL, while 35 million of these have levels of 240...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Precision Medicine, Provider, Technology
Estonian Biobank to Sequence 10,000 Genomes as Part of Precision Medicine Project
Precision Immune Start-Up Mirador Launches with $400M+
The future of companion diagnostic (CDx) development: Why commercialization is key
STAT+: Drug development was once a marathon. New tools and timelines are turning it into a sprint
Precision Medicine Startup Mirador Unveils $400M for R&D of New I&I Drugs

Share This Article